Key Takeaways GLP-1 medications slow digestion, which can lead to nausea, bloating, reflux, gas, and changes in bowel habits
Additionally, the somatostatin receptor Sstr5 expression is present in GLP-1-immunoreactive cells (Jepsen et al., 2019)
Studies have found that many people regain weight after stopping weight loss injections, as renewed hunger and cravings drive them to increase their calorie intake
At this level, you may also qualify for bariatric surgery referrals, though many patients prefer trying GLP-1 therapy first
Licensed levocarnitine (Carnitor) for deficiency states is prescribed under specialist supervision with dosing based on clinical indication and body weight
Proper semaglutide dosing follows a specific titration schedule starting at 0.25mg and gradually increasing